158 related articles for article (PubMed ID: 36820554)
1. Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma.
Huang Q; Yan J; Jiang Q; Guo F; Mo L; Deng T
Medicine (Baltimore); 2023 Feb; 102(6):e32793. PubMed ID: 36820554
[TBL] [Abstract][Full Text] [Related]
2. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
Zhou W; Zhang W
BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
[TBL] [Abstract][Full Text] [Related]
3. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
[No Abstract] [Full Text] [Related]
4. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
6. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
Qu G; Wang D; Xu W; Guo W
Front Genet; 2022; 13():867627. PubMed ID: 35559014
[No Abstract] [Full Text] [Related]
8. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer.
Xue S; Shen K; Wang K; Ge W; Mao T; Li S; Zhang X; Xu H; Wang Y; Yao J; Yue M; Ma J; Wang Y; Shentu D; Cui J; Wang L
Dis Markers; 2022; 2022():5634887. PubMed ID: 36618967
[TBL] [Abstract][Full Text] [Related]
10. Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy.
Zhou X; Yao L; Zhou X; Cong R; Luan J; Wei X; Zhang X; Song N
Front Oncol; 2022; 12():837155. PubMed ID: 35860590
[TBL] [Abstract][Full Text] [Related]
11. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma.
Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X
Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836
[No Abstract] [Full Text] [Related]
13. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma.
He J; Zhou W; Zhang M
Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
15. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue.
Ma S; Zhao H; Wang F; Peng L; Zhang H; Wang Z; Jiang F; Zhang D; Yin M; Li S; Huang J; Liu Z; Tao S
Aging (Albany NY); 2023 Mar; 15(5):1628-1651. PubMed ID: 36917093
[TBL] [Abstract][Full Text] [Related]
17. A prognostic signature of pyroptosis-related lncRNAs verified in gastric cancer samples to predict the immunotherapy and chemotherapy drug sensitivity.
Wang Y; Chen X; Jiang F; Shen Y; Fang F; Li Q; Yang C; Dong Y; Shen X
Front Genet; 2022; 13():939439. PubMed ID: 36147488
[No Abstract] [Full Text] [Related]
18. Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer.
Li R; Zhao M; Sun M; Miao C; Lu J
PeerJ; 2023; 11():e15884. PubMed ID: 37671354
[TBL] [Abstract][Full Text] [Related]
19. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
20. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
